Extracellular S100A4 induces smooth muscle cell phenotypic transition mediated by RAGE

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 9, 2015, Pages 2144-2157

  Chaabane, Chiraz ^a   Heizmann, Claus W ^b   Bochaton Piallat, Marie Luce ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Atherosclerosis; EF hand; PDGF BB; RAGE; Restenosis; S100A4

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALVASCULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUTRALIZING ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CULTURE MEDIUM; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN RECEPTOR; PROTEIN S 100; S100A4 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CORONARY ARTERY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL MOTION; CULTURE MEDIUM; GENETICS; METABOLISM; PATHOLOGY; PIG;

ANIMALS; ANTIGENS, DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; HUMANS; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SWINE;

EID: 84941129887     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.07.022     Document Type: Article

References (43)

1. Stenmark K.R., Fagan K.A., Frid M.G. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ. Res. 2006, 99:675-691.
2. Chaabane C., Otsuka F., Virmani R., Bochaton-Piallat M.L. Biological responses in stented arteries. Cardiovasc. Res. 2013, 99:353-363.
3. Hao H., Ropraz P., Verin V., Camenzind E., Geinoz A., Pepper M.S., Gabbiani G., Bochaton-Piallat M.L. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1093-1099.
4. Brisset A.C., Hao H., Camenzind E., Bacchetta M., Geinoz A., Sanchez J.C., Chaponnier C., Gabbiani G., Bochaton-Piallat M.L. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ. Res. 2007, 100:1055-1062.
5. Coen M., Marchetti G., Palagi P.M., Zerbinati C., Guastella G., Gagliano T., Bernardi F., Mascoli F., Bochaton-Piallat M.L. Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque. Am. J. Pathol. 2013, 183:996-1009.
6. 2+ signaling S100 proteins and RAGE in translational medicine. Front. Biosci. (Schol. Ed.) 2011, 3:1232-1262.
7. Gross S.R., Sin C.G., Barraclough R., Rudland P.S. Joining S100 proteins and migration: for better or for worse, in sickness and in health. Cell. Mol. Life Sci. 2014, 71:1551-1579.
8. Sherbet G.V. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett. 2009, 280:15-30.
9. Grigorian M., Ambartsumian N., Lukanidin E. Metastasis-inducing S100A4 protein: implication in non-malignant human pathologies. Curr. Mol. Med. 2008, 8:492-496.
10. Dahlmann M., Okhrimenko A., Marcinkowski P., Osterland M., Herrmann P., Smith J., Heizmann C.W., Schlag P.M., Stein U. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis. Oncotarget 2014, 5:3220-3233.
11. Yammani R.R., Long D., Loeser R.F. Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes. Arthritis Rheum. 2009, 60:792-800.
12. Hsieh H.L., Schafer B.W., Weigle B., Heizmann C.W. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem. Biophys. Res. Commun. 2004, 316:949-959.
13. Fernandez-Fernandez M.R., Veprintsev D.B., Fersht A.R. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4735-4740.
14. Lukanidin E., Sleeman J.P. Building the niche: the role of the S100 proteins in metastatic growth. Semin. Cancer Biol. 2012, 22:216-225.
15. Klingelhofer J., Moller H.D., Sumer E.U., Berg C.H., Poulsen M., Kiryushko D., Soroka V., Ambartsumian N., Grigorian M., Lukanidin E.M. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein. FEBS J. 2009, 276:5936-5948.
16. Kim E.J., Helfman D.M. Characterization of the metastasis-associated protein, S100A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin. J. Biol. Chem. 2003, 278:30063-30073.
17. Mandinova A., Atar D., Schafer B.W., Spiess M., Aebi U., Heizmann C.W. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci. 1998, 111(Pt 14):2043-2054.
18. Takenaga K., Nakamura Y., Sakiyama S., Hasegawa Y., Sato K., Endo H. Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J. Cell Biol. 1994, 124:757-768.
19. Frid M.G., Li M., Gnanasekharan M., Burke D.L., Fragoso M., Strassheim D., Sylman J.L., Stenmark K.R. Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L1059-L1072.
20. Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D., Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 1986, 103:2787-2796.
21. Stouffer G.A., Owens G.K. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-b. Circ. Res. 1992, 70:820-828.
22. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
23. Yoshida T., Owens G.K. Molecular determinants of vascular smooth muscle cell diversity. Circ. Res. 2005, 96:280-291.
24. Leclerc E. Measuring binding of S100 proteins to RAGE by surface plasmon resonance. Methods Mol. Biol. 2013, 963:201-213.
25. Arumugam T., Ramachandran V., Gomez S.B., Schmidt A.M., Logsdon C.D. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin. Cancer Res. 2012, 18:4356-4364.
26. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 2003, 60:540-551.
27. Hsieh H.L., Schafer B.W., Cox J.A., Heizmann C.W. S100A13 and S100A6 exhibit distinct translocation pathways in endothelial cells. J. Cell Sci. 2002, 115:3149-3158.
28. Schmidt-Hansen B., Ornas D., Grigorian M., Klingelhofer J., Tulchinsky E., Lukanidin E., Ambartsumian N. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004, 23:5487-5495.
29. Semov A., Moreno M.J., Onichtchenko A., Abulrob A., Ball M., Ekiel I., Pietrzynski G., Stanimirovic D., Alakhov V. Metastasis-associated protein S100A4 induces angiogenesis through interaction with annexin II and accelerated plasmin formation. J. Biol. Chem. 2005, 280:20833-20841.
30. Carvalho S.B., Botelho H.M., Leal S.S., Cardoso I., Fritz G., Gomes C.M. Intrinsically disordered and aggregation prone regions underlie beta-aggregation in S100 proteins. PLoS One 2013, 8:e76629.
31. Lawrie A., Spiekerkoetter E., Martinez E.C., Ambartsumian N., Sheward W.J., MacLean M.R., Harmar A.J., Schmidt A.M., Lukanidin E., Rabinovitch M. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ. Res. 2005, 97:227-235.
32. Kiryushko D., Novitskaya V., Soroka V., Klingelhofer J., Lukanidin E., Berezin V., Bock E. Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein. Mol. Cell. Biol. 2006, 26:3625-3638.
33. Naka Y., Bucciarelli L.G., Wendt T., Lee L.K., Rong L.L., Ramasamy R., Yan S.F., Schmidt A.M. RAGE axis: animal models and novel insights into the vascular complications of diabetes. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1342-1349.
34. Wautier J.L., Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction. Circ. Res. 2004, 95:233-238.
35. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. (Berl.) 2005, 83:876-886.
36. Burke A.P., Kolodgie F.D., Zieske A., Fowler D.R., Weber D.K., Varghese P.J., Farb A., Virmani R. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1266-1271.
37. Spiekerkoetter E., Guignabert C., de Jesus Perez V., Alastalo T.P., Powers J.M., Wang L., Lawrie A., Ambartsumian N., Schmidt A.M., Berryman M., Ashley R.H., Rabinovitch M. S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ. Res. 2009, 105:639-647.
38. Cerezo L.A., Remakova M., Tomcik M., Gay S., Neidhart M., Lukanidin E., Pavelka K., Grigorian M., Vencovsky J., Senolt L. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 2014, 53:1520-1526.
39. Ibrahim Z.A., Armour C.L., Phipps S., Sukkar M.B. RAGE and TLRs: relatives, friends or neighbours?. Mol. Immunol. 2013, 56:739-744.
40. Rouhiainen A., Kuja-Panula J., Tumova S., Rauvala H. RAGE-mediated cell signaling. Methods Mol. Biol. 2013, 963:239-263.
41. Newby A.C. Matrix metalloproteinase inhibition therapy for vascular diseases. Vasc. Pharmacol. 2012, 56:232-244.
42. Huang W.C., Sala-Newby G.B., Susana A., Johnson J.L., Newby A.C. Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-kappaB. PLoS One 2012, 7:e42507.
43. Gomez D., Owens G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc. Res. 2012, 95:156-164.